Frame
Define the investment question and exact product being underwritten.
Investor Hub
Decision tools and expert-reviewed regulatory due diligence for investors backing hardware, connected devices, cosmetics, wellness and other physical products entering Europe.
For venture funds, corporate venture teams, accelerators and venture studios.
Start with the questions
Regulatory due diligence for investors tests whether a physical-product company’s proposed EU route, evidence, budget and launch timeline support the investment case. It connects the exact product and claims to classification logic, technical evidence, market-entry cost, critical dependencies and management ownership. The result is not a generic compliance score: it identifies which assumptions are supported, which remain open, how strongly the available evidence supports the conclusion and what must happen before or after closing. Investors can use the same method for an initial screen, a live transaction, data-room preparation or portfolio prioritisation.
Open the investor checklistChoose your question
Start with the decision you need to make. Every path keeps evidence, uncertainty and next action visible.
Challenge the route, evidence, capital requirement and critical path behind a live investment case.
Compare route confidence, capital exposure and timeline risk across portfolio companies.
See how findings, confidence, financing impact and conditions precedent can fit into one decision note.
Screen product definition, classification, evidence, budget, timeline, ownership and post-market control.
Understand the assessment method, confidence language, human review, AI limits and document-handling boundary.
From question to control
A useful output changes a decision, a budget, a condition precedent or a board milestone.
Define the investment question and exact product being underwritten.
Trace claims to route, evidence, cost and launch dependencies.
Show ranges, unknowns and the impact on runway or follow-on capital.
Assign evidence, owners, decision dates and escalation conditions.
Investor questions
Use these boundaries when deciding whether a screen, deal review or portfolio review fits the question.
Regulatory due diligence for investors tests whether a physical-product company’s proposed EU route, evidence, budget and launch timeline support the investment case. It identifies material assumptions, confidence levels, financing exposure and the evidence needed before or after closing.
Deal Gate addresses one live transaction and produces decision conditions and milestones. Portfolio Gate applies a consistent screen across multiple companies so a fund can compare exposure and decide where deeper review or board intervention is needed.
No. Regulatory Gate provides indicative, expert-reviewed decision support. It does not provide an investment recommendation, legal opinion, formal classification or product certification, and it may recommend specialist validation for higher-risk or borderline products.
The investor review is designed for companies building physical products such as hardware, connected devices, electronics, cosmetics and consumer or wellness products that plan to enter the European market.
Investor pilot
Choose a live deal, portfolio question or accelerator cohort. Scope, evidence boundary and information handling are agreed before review begins.